Evidence map›Paper›PMID 42170246›Full record

ArticleChina CDC weekly2026

Epidemiological Characteristics and Transmissibility of Human Immunodeficiency Virus - Fujian Province, China, 1987-2024.

Mingya Zhang, Yanshu Ke, Yue He, Qiaoling Lian, Chunyang Zhang, Shaobin Wu, Zhenghua Wang, Xiaoli Lu, Meirong Xie, Shouli Wu and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in China CDC weekly, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Mingya Zhang *Fujian Provincial Key Laboratory of Zoonosis Research, Fujian Provincial Center for Disease Control and Prevention, Fujian Provincial Academy of Preventive Medicine Fuzhou City, Fujian Province, China.
Yanshu Ke *State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration in Vaccine Research, Xiamen University, Xiamen City, Fujian Province, China.
Yue He *State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen City, Fujian Province, China.
Qiaoling LianFujian Provincial Key Laboratory of Zoonosis Research, Fujian Provincial Center for Disease Control and Prevention, Fujian Provincial Academy of Preventive Medicine Fuzhou City, Fujian Province, China.
Chunyang ZhangFujian Provincial Key Laboratory of Zoonosis Research, Fujian Provincial Center for Disease Control and Prevention, Fujian Provincial Academy of Preventive Medicine Fuzhou City, Fujian Province, China.
Shaobin WuFujian Provincial Key Laboratory of Zoonosis Research, Fujian Provincial Center for Disease Control and Prevention, Fujian Provincial Academy of Preventive Medicine Fuzhou City, Fujian Province, China.
Zhenghua WangFujian Provincial Key Laboratory of Zoonosis Research, Fujian Provincial Center for Disease Control and Prevention, Fujian Provincial Academy of Preventive Medicine Fuzhou City, Fujian Province, China.
Xiaoli LuFujian Provincial Key Laboratory of Zoonosis Research, Fujian Provincial Center for Disease Control and Prevention, Fujian Provincial Academy of Preventive Medicine Fuzhou City, Fujian Province, China.
Meirong XieFujian Provincial Key Laboratory of Zoonosis Research, Fujian Provincial Center for Disease Control and Prevention, Fujian Provincial Academy of Preventive Medicine Fuzhou City, Fujian Province, China.
Shouli WuFujian Provincial Key Laboratory of Zoonosis Research, Fujian Provincial Center for Disease Control and Prevention, Fujian Provincial Academy of Preventive Medicine Fuzhou City, Fujian Province, China.
Jianfeng XieFujian Provincial Key Laboratory of Zoonosis Research, Fujian Provincial Center for Disease Control and Prevention, Fujian Provincial Academy of Preventive Medicine Fuzhou City, Fujian Province, China.
Zeyu ZhaoState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration in Vaccine Research, Xiamen University, Xiamen City, Fujian Province, China.
Jia RuiDepartment of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha City, Hunan Province, China.
Tianmu ChenState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration in Vaccine Research, Xiamen University, Xiamen City, Fujian Province, China.
Yuefeng QiuFujian Provincial Key Laboratory of Zoonosis Research, Fujian Provincial Center for Disease Control and Prevention, Fujian Provincial Academy of Preventive Medicine Fuzhou City, Fujian Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

What is already known about this topic?: Given the proportion of undiagnosed human immunodeficiency virus (HIV) cases and regional disparities in Fujian Province, achieving the 2030 targets to end acquired immunodeficiency syndrome (AIDS) remains uncertain. What is added by this report?: HIV transmission in Fujian has stabilized through treatment and viral suppression, achieving the "95-95-95" targets; however, a diagnostic gap persists (86.30%). Transmissibility recently increased ( What are the implications for public health practice?: Improving diagnostic coverage is essential for epidemic elimination. Targeted screening and self-testing must be intensified among key populations, particularly middle-aged and older adults, while maintaining treatment achievements to prevent resurgence.

Indexed as

Acquired immune deficiency syndromeHuman immunodeficiency virusTransmissibilityTransmission dynamics model

Identifiers

PMID42170246
PMCPMC13187651

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.